Dr Robin Scaife
Principal researcher Dr Scaife discovered a new class of anti-mitotic drugs that has now undergone extensive development toward pre-clinical testing of anti-cancer activity.
Welcome to Grandbridge
Grandbridge Limited (Grandbridge) is an investment company publicly listed on the Australian Stock Exchange under the code “GBA”.
The principal activity of Grandbridge is the development of companies, products and services within the private and public equity markets of Australia, USA, Europe and Asia.
Grandbridge also provides corporate advisory services to a select group of private and publicly listed companies.
Latest News
|
|
The New Seaclem-1 well, concluded in January 2011. The well obtained a significant volume of valuable and new information about the offshore Sydney Basin – a previously unexplored area off NSW. Click here to read more |
MDSystems – Drug Discovery MDSystems has core expertise in high-content and high-throughput imaging and analysis, providing services for researchers worldwide. |
